Shares of Kinder Morgan, Inc. (NYSE:KMI) opened at $18.98, and ended 0.53% higher at $19.05. Nearly 9.3 million shares were traded by the close, lower than its average daily volume of 9.67 million shares.Kinder Morgan, Inc. (KMI) Analyst Opinion
Kinder Morgan, Inc. has a consensus outperform rating from 20 Wall Street analysts, and the number of shares currently sold short amount to at least 1.86% of shares outstanding. The stock sank -1.6% last month and is down -8.02 this year. Wall Street is only getting more bullish on the stock, with 13 of analysts who cover KMI having a buy-equivalent rating. Analysts have placed a $24.72 price target on Kinder Morgan, Inc., suggesting a 29.76% gain from recent close. It’s currently trading about -17.21% below its 52-week high.
Kinder Morgan, Inc. (KMI) failed to surprise the stock market in its last reported earnings when it earned $0.14 a piece versus the consensus-estimated $0.15. Its revenue totaled $3.11 billion down -9.14% from the previous quarter.Kinder Morgan, Inc. (NYSE:KMI) Intraday View
This stock (KMI) is ahead of its 52-week low with 4.5%. Its last month’s stock price volatility remained 1.15% which for the week stands at 1.31%. The share price has moved backward from its 20 days moving average, trading at a distance of -1.13% and stays -1.22% away from its 50 days moving average. Over the last five days, shares have managed 1.22% gains and now is down -6.44% since hitting its 200-day moving average of $19.7. Kinder Morgan, Inc. (KMI) has made its way to a 12-month decline of -8.5%.
Turning to Abbott Laboratories (NYSE:ABT), its shares were trading at $54.44 a retreat of $-0.96, on the trading floor. The stock, after opening at $55.26, touched a high of $55.35 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2. Abbott Laboratories has 8 buy ratings, 7 holds and 0 sells even after the stock tumbled -1.79% from its high of $55.43 to a $94.75 billion market value through last close.
The company’s consensus rating on Reuter’s scale remained unchanged from 1.95 to 1.95 during a month. Analysts set a 12-month price target of $55.76 a share. The target implies a 2.42% spike from where the shares are currently trading. Also, the current price highlights a discount of 17.56% to analysts’ high consensus price target.Abbott Laboratories (NYSE:ABT) Intraday Trading
The counter witnessed a trading volume of 6.87 million shares versus an average volume of 5.49 million shares during last trading session. Its last month’s stock price volatility remained 1.35% which for the week approaches 1.31%. The lowest price the stock reached in the last trading day was $54.32 and compares with the $37.38 52-week low. The stock recovered 45.64% since its low point and has performed 41.73% year-to-date.